MIG Capital is one of the leading German VC investors. Through its MIG Fonds, MIG invests in young deep tech and life sciences companies in German-speaking Europe and beyond. To date, the company has invested more than €770 million in nearly 60 startups. The MIG investment portfolio currently consists of over 30 companies. MIG’s investment team is made up of a dedicated group of engineers, scientists, physicians and entrepreneurs who use analytical and creative processes to assess the risks and opportunities of business models and technologies. Their reputation, experience and network provide excellent access to companies, institutions and decision-makers to support the growth of their portfolio companies.

Phone number: +49 89 94382680 
Email: [email protected]
Address: Ismaninger Str. 102, D-81675 Munich, Germany

Website: www.mig.ag
Social media:
LinkedIn: MIG Capital

Investment focus: MIG Capital is focused on life sciences and deep tech start-ups. Portfolio companies develop innovations in areas including biopharmaceuticals, medical technology, digital health, energy and environmental technologies, advanced computing, digitalization and IoT.

Founded in: 2004/2005
Board of Directors: Michael Motschmann, Dr. Matthias Kromayer, Kristian Schmidt-Garve, Jürgen Kosch

Number of portfolio companies: over 30

Portfolio companies (examples): IQM, Amsilk, Hawcell, iOmx, Konux, Look Up Space, Temedica, Zadient